This review summarizes phase I trial results of 11 drugs presented at the American Society of Clinical Oncology meeting held in Chicago IL from May 30 to June 3rd 2008: BMS-663513, CT-322, CVX-045, GDC-0449, GRN163L, LY2181308, PF-00562271, RAV12, RTA 402, XL765, and the survivin vaccine.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2647552 | PMC |
| http://dx.doi.org/10.1186/1756-8722-1-20 | DOI Listing |
Publication Analysis
Top Keywords
american society
8
society clinical
8
clinical oncology
8
oncology meeting
8
first-in-class first-in-human
4
first-in-human phase
4
phase targeted
4
targeted agents
4
agents highlights
4
highlights 2008
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!